What is the dosage frequency of Zenhale (mometasone/formoterol) for a 37-year-old woman with uncontrolled asthma, previously on Ventolin (albuterol) and Flovent (fluticasone), during and after a cold?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Zenhale (Mometasone/Formoterol) for Uncontrolled Asthma During and After a Cold

For this 37-year-old woman with uncontrolled asthma, Zenhale (mometasone/formoterol) should be taken as two inhalations twice daily during a cold, and then continued at two inhalations twice daily as maintenance therapy with reassessment in 2-4 weeks after starting treatment.

Dosing During a Cold

When experiencing a cold, patients with asthma often have worsening symptoms that can trigger exacerbations. For this patient with uncontrolled asthma (daily symptoms, frequent wheeze, multiple uses of Ventolin):

  • During a cold: Maintain Zenhale at two inhalations twice daily (morning and evening) 1
  • Continue to use Ventolin (albuterol) as needed for breakthrough symptoms
  • If symptoms worsen significantly during the cold, a short course of oral corticosteroids may be considered 1
  • The combination of inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) in Zenhale helps reduce cold-related exacerbations by up to 36% compared to other regimens 2

Maintenance Dosing After the Cold

After the cold resolves:

  • Continue Zenhale at two inhalations twice daily 3
  • This dosing is appropriate for a patient with uncontrolled symptoms who was previously on Flovent (fluticasone) and is now requiring step-up therapy
  • The mometasone component provides anti-inflammatory effects while formoterol provides both immediate and long-acting bronchodilation

Timing of Reassessment

  • Reassess the patient in 2-4 weeks after starting Zenhale therapy 1, 3
  • At this follow-up visit, evaluate:
    • Symptom control (frequency of daytime and nighttime symptoms)
    • Frequency of rescue medication use
    • Lung function (PEF or spirometry if available)
    • Proper inhaler technique
    • Medication adherence
    • Any side effects

Monitoring and Adjustments

  • If symptoms are well-controlled after 3 months of therapy, consider stepping down by reducing to one inhalation twice daily 1
  • If symptoms remain uncontrolled at the 2-4 week follow-up, consider:
    1. Checking inhaler technique
    2. Assessing adherence
    3. Identifying potential triggers
    4. Adding additional controller medication
    5. Referral to a specialist if symptoms remain poorly controlled 3

Important Considerations

  • Mometasone/formoterol provides both maintenance and quick relief due to the rapid onset of formoterol 4
  • Evening dosing of mometasone has been shown to be particularly effective for controlling nocturnal symptoms 5
  • Patients should rinse their mouth after using Zenhale to prevent oral candidiasis 3
  • Formoterol should never be used alone for asthma management due to increased risk of asthma-related death 6

Patient Education

  • Instruct the patient on proper inhaler technique
  • Create a written asthma action plan that includes what to do during a cold or exacerbation
  • Emphasize the importance of taking the medication regularly, even when feeling well
  • Explain that the medication contains both a controller (mometasone) and a bronchodilator (formoterol)
  • Advise that improvement may be seen within days, but optimal benefit may take 1-2 weeks

This approach provides optimal control of asthma symptoms while minimizing the risk of exacerbations, particularly during respiratory infections, which are common triggers for this patient.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A Practical Guide to Implementing SMART in Asthma Management.

The journal of allergy and clinical immunology. In practice, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.